An Open Label, Single arm Clinical Study to Evaluate the efficacy of Ambic Chahel Tablets in patients having Stress Issues - NI

Ambic Ayurved India Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Subject from 18-65 years of age.
•2.Subject suffering from one or multiple mental health Issues from- anxiety, insomnia, depression etc;
•3.Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study.
•4.Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.

•1.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids.
•2.Subjects that have participated in any other interventional clinical trial in the previous 30 days.
•3.Subjects with known sensitivity to any of the constituents of the investigational product.

发起方

Ambic Ayurved India Pvt. Ltd.